UNSPSC 51281603: Apramycin

This classification denotes an antibiotic with the molecular formula C21H41N5O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 388K3TR36Z, chemically known as 4-o-((8r)-2-amino-8-o-(4-amino-4-deoxy-alpha-d-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-d-glycero-alpha-d-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-d-streptamine but generally known as apramycin, which bears US NIH Compound Identifier 71428. Apramycin most often comes in base and sulphate forms.

UNSPSC 51281603 Apramycin is a Commodity code that nominally covers a specific antibiotic pharmaceutical product, but state and local procurement activity under this code shows little direct relevance to apramycin itself. Recent solicitations tagged to this code instead reflect broader pharmaceutical and medical supply procurement — notably naloxone and drug deactivation systems for community health initiatives, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and medical and first aid supplies for emergency response. The issuing bodies span county health departments, state HHS commissions, municipalities, and multi-state cooperative purchasing alliances, indicating that when this code appears in state and local procurement, it typically signals solicitations for packaged pharmaceuticals, emergency medical consumables, or OTC products rather than apramycin specifically.

Recent activity concentrates in Florida and Minnesota, with secondary representation from Texas and multi-jurisdictional cooperative purchasing. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for the county community health building, with quarterly deliveries and a two-year initial term plus one-year renewal option. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 (posted January 20, 2026, responses due March 26, 2026) to establish contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, requiring vendors to supply through three authorized wholesalers and comply with cGMP and DSCSA certification. The City of Tampa's Purchasing Department issued IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies including respiratory equipment, cardiac monitoring electrodes, and consumables for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered-market designation for certified Small Local Business Enterprises. The code shows sparse recent activity and poor alignment with its nominal scope, suggesting limited direct procurement pursuit under apramycin specifically.